1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALKERMES PLC
Alkermes plc XNAS: ALKS
Mid-range Performer
Download real time
30.25 0.15 (0.50%)
2.0M
XNAS Volume

XNAS 02 Mar, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Alkermes PLC took place on 02 Mar 2026, for the purpose of the TD Cowen 46 Annual Health Care Conference See details

Alkermes PLC - ALKS - stock price prediction, stock price target, analyst ratings from 18 analysts

Alkermes PLC has a share price target of US$ 44, revenue growth forecast of -5.5%, and profit growth estimate of -32.2% for FY25, based on top 18 analyst calls.

Forecaster Screeners